Comment from Anonymous
AnonymousOpposeIndividual
Summary: Adele Kootz expresses strong opposition to the proposed action, arguing that the FDA should maintain and strengthen safety protocols for mifepristone. She cites concerns regarding PTSD, potential for non-consensual use, and reports of adverse events and deaths associated with the drug.
The abortion pill is causing and has BEEN causing women to have PTSD as they now are having abortions in THEIR OWN BATHROOMS and then SEEING their BABY in the toilet! OR they go to the ER because they are hemorrhaging! The battle on women continues. How this protocol became legal in the first place is a disgrace.
Not only do women have PTSD, now men who don’t want to parent and get rid of the NORMAL consequence of engaging in sexual intercourse can slip the pills to the women without their knowledge or CONSENT. The abortion pill IN NO WAY helps women. It helps men escape responsibility even more than surgical abortion.
I am strongly opposed to the FDA weakening safety protocols and removing the Risk Evaluation and Mitigation Strategy (REMs) safety requirements for the abortion drug mifepristone. Drugs with significant risks must be strictly regulated, and mifepristone is no exception. FDA data links this drug to at least 36 deaths and thousands of adverse events. A 2024 Ethics and Public Policy Center report found that 11% of chemical abortions resulted in adverse events.
When a drug poses such dangers to women’s health and lives, robust safety measures are essential. I urge the FDA to maintain—and strengthen—current safety protocols for mifepristone to protect women nationwide.
Signed, Adele Kootz